chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Numbness and tingling started suddenly in the left arm and the left foot a week after the Moderna vaccination was given.  Patient states it feels as if his foot and arm is asleep all the time like he slept on it all night. He has no weakness and is able to function however he states the numbness and tingling is very uncomfortable. Blood clots have been ruled out at this time by his provider. He states he has no other symptoms at this time although he did have a high fever the day after he received the vaccine of 102.7 F.
vaccinations don't work never again; vaccinations don't work never again; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), Program ID:. The reporter is the patient.  An adult male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "vaccinations don't work never again". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
night p/pt recvd vax supposedly had tonic sz & was taken to hosp & evaluated for sz workup-afebrile;
Itchy redness surrounding injection site and spreading down arm. Pt states no treatment. Pt states sx started 24 hr after injection.
Chest pain starting at 8pm on 7/17/21 after vaccine. Pericarditis, elevated troponin, EKG changes consistent with pericarditis.
pt recv vax 10APR96 & devel a knot @ the inj site, & swelling, redness, warmth;also devel a fever;this is one of two patients from this site & lot# to report adverse rxn;addtl info recv 5JUN96 indicated that the pt remained recovered;
I was playing golf on 07/22/2021 and I collapsed on the 18th hole of the golf course. It was a hot day and we were walking the golf course. I had had no problems that day or before that point. I was given CPR and taken to the hospital. I have no memory of events that whole week. I was diagnosed with Cardiac Arrest and they said it was a Primary Electrical Event. I was given Heart Catheterization but there was no blockage. I was given an implantable defibrillator after that. I was hospitalized and transferred to another hospital. During my stay it was also discovered that I had a mass on my left kidney on 07/22/2021 and I am scheduled for surgery.
Tdap injection 3/18/09 left deltoid, 3/19/09 wife noticed red ring around injection site.  Pt. didn't sleep all night due to left arm & pain up in left side of neck.  3/20/09 wife had to help get robe on d/t. pain in left arm.  She helped to kitchen and while sitting in chair felt faint, eyes rolled back and wife eased to floor.  Daughter and wife took patient to ER.
This spontaneous report as received from a physician via a company representative refers to a female patient of unknown age. On an unknown date the patient was vaccinated with a dose of ZOSTAVAX (lot# and route not of reported), standard dose (estimated as 0.65 ml). On an unknown date the patient experienced shingles accompanied by pain after receiving ZOSTAVAX. Patient sought medical attention via office visit. The outcome of the events was unknown. Additional information has been requested.
Soreness on at the injection site; drowsiness during they day of theinjection; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3248) via an unspecified route of administration on 02Mar2021 at 10:15 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Mar2021, the patient experienced Soreness on at the injection site and drowsiness during the day of the injection. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event Soreness on at the injection site and drowsiness was recovered on an unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
I had fluid in the lung the night of the second shot and could not lie horizontal for 60 hours.  This happened two weeks earlier six days after the first vaccine but possibly due to an unrelated procedure.
Pfizer-BioNTech COVID-19 Vaccine  1st and 2nd day had side effect of chills for a couple hours each day and low grade fever the 2nd day.  No side effects the 3rd day.
Twitching around pt's mouth. Started day after vaccination (Day 7 rabies vaccine administered on 6/12/23) and lasted around couple of hours. Pt also reported feeling swollen, puffy and having swollen lymph nodes.  Day after getting Day 3 Rabies vaccine (on 6/8/23), pt. reported numbness of her left check that lasted couple of hours and extreme weakness.
redness at injection site; sore arm at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (redness at injection site) and VACCINATION SITE PAIN (sore arm at injection site) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination.     no medical history was reported.     On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness at injection site) and VACCINATION SITE PAIN (sore arm at injection site). At the time of the report, VACCINATION SITE ERYTHEMA (redness at injection site) and VACCINATION SITE PAIN (sore arm at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       There is no concomitant list   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: No specific follow-up information recorded.
Pt recv vax on 11/2/98; on 11/4/98 pt exp pain of LA, red/ swelling of LA; tx=Ceflexin
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 41-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 29Jan2021 as dose 1, single (Lot number: el3247), in left arm and on 19Feb2021 as dose 2, single (Lot number: el9269) at the age of 39 years, in left arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 08Dec2021 as dose 3 (booster), single (Lot number: 060h21a), in left arm for covid-19 immunisation. The patient's relevant medical history included: "depression" (unspecified if ongoing); "anxiety" (unspecified if ongoing); "seasonal allergies" (unspecified if ongoing); "insomnia" (unspecified if ongoing); "acid refluxmigraines" (unspecified if ongoing); "migraine" (unspecified if ongoing). There were no concomitant medications. Past drug history included: Benadryl, reaction(s): "known allergies: benadryl". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2022) Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical information: other medication in 2weeks was no. Patient received paxlovid,  indication was treatment of COVID-19treatment start date was 03Aug2022.; Sender's Comments: Based on the information in the case report, a causal association between reported events vaccination failure, Covid 19 and suspect BNT162B2 cannot be excluded.
ITCHING AND FLUSHING.  BP: 130/94, PULSE: 80'S, SpO2: 100% WAS GIVEN 50MG BENADRYL AND SYMPTOMS RESOLVED.
Information has been received from a registered nurse concerning a 48 year old female patient with no pertinent medical history who on 20-OCT-2009 was vaccinated intramuscularly with the first 0.5 ml dose of PNEUMOVAX 23 (lot# 663369/0506Y). There was no concomitant medication. On 21-OCT-2009 the patient experienced red, warm to touch, and swelling at the site of injection after receiving her first dose of PNEUMOVAX 23. The affected area was large. The patient also had a fever on 21-OCT-2009. The patient sought medical attention via office visit. No laboratory diagnostics studies were performed. The patient was treated with BENADRYL, ADVIL or TYLENOL as needed. At the time of the report, the patient had not recovered. Additional information has been requested.
Reported generalized rash, itching and hives within two hours of vaccine administration. Treated in Emergency around 7pm Room with Benadryl and Steroids. No respiratory symptoms reported.
I was a little tired; I had a slight fever; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (I was a little tired) and PYREXIA (I had a slight fever) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A and 052E21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes and Polymyalgia rheumatica. Concomitant products included INSULIN, METFORMIN and DULAGLUTIDE (TRULICITY) for Diabetes, METHOTREXATE for Polymyalgia rheumatica, LISINOPRIL for an unknown indication.   On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (I was a little tired) and PYREXIA (I had a slight fever). At the time of the report, FATIGUE (I was a little tired) and PYREXIA (I had a slight fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication Fibric acid for the indication of Diabetes was reported. No Treatment medications were provided.   This case was linked to MOD-2021-301830 (Patient Link).
Information has been received from a registered nurse concerning a 20 year old female, with no medical history or history of drug reactions/allergies who on 12-MAR-2007 was vaccinated with 0.5 ml intramuscular Gardasil (lot# 654741/0013U). Concomitant therapy included Alesse. Subsequently the patient experienced nausea and vomiting. Patient outcome was unknown. No lab testing was performed. Additional information has been requested. The registered nurse reported that 3 other patients' experiences after Gardasil administration (WAES 0703USA02859, WAES 0703USA02797, WAES0703USA02815). This is in follow-up to report (s) previously submittedon 4/13/2007. The records of testing prior to release of the lot in question, have been rechecked and found to be satisfactory. The lot complies with the standards of the Center for Biological Evaluation & Research, and was released.
I was told via phone message to report the adverse event, but I don't think I had one.  I just happened to get sick a month after the vaccine with congestion, cold, virus type illness. Covid test is negative.
Patient received a Flumist vaccine at age 56. No signs or symptoms of any reaction.
1/5 dollar induration, erythema, fever 103.1 for 1 day from 103.  Itch - all symptoms gone in 24 hours.
tested positive for SARS-CoV2 on  10/28/2021 due to routine testing in Labor and Delivery at a local hospital. Patient is asymptomatic for covid symptoms
Started crying 2 hrs post DTaP, Comvax, polio vac. Went to sleep awoke screaming 1 1/4 hrs later. Mom gave 40mg Tylenol. Baby examined in clinic at 3:45pm. Was beginning to settle-consolable-gave add'l 80mg Tylenol.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 02-APR-2015, the patient was inoculated with ZOSTAVAX at a pharmacy as recommended for routine adult health maintenance and for the prevention of shingles (lot #, dose and route not provided). The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 09-MAY-2016 the patient was treated at Internal Medicine for the onset of severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as severe herpes zoster, or shingles. The patient was prescribed valacyclovir and prednisone for management of her painful symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
I had a sudden onset of racing heart, shortness of breath, and a crackling sound when I would exhale starting on 4/19/21. I went to the doctor on 4/22/21 where they did a COVID swab (negative), a chest x-ray, and a d-dimer blood test. My d-dimer value was 4520, so the clinic immediately sent me to the ER. At the ER, they did another COVID swab (negative), a chest x-ray, a CT scan with contrast dye, and an EKG. The CT scan found multiple pulmonary emboli in my lungs, including a large one near my heart. I was admitted to the hospital from 4/22/21-4/24/21. They started me on blood thinners (Xarelto) and did an ultrasound of my heart, in which they determined my heart has not sustained damage. The shortness of breath subsided in about a week post-hospitalization. I am still on daily blood thinners.
Fever with Tmax 101.6F starting approximately 6hours after vaccination. On 8/15/2021, developed chest pain. Presented to ED where found to have elevated troponin (17.8) and EKG with ST segment changes, consistent with myopericarditis. Normal cardiac function at this time. Treating with NSAIDs.
Patient was given second dose of Moderna Covid-19 vaccination 1 week too early. Given 3 weeks after first injection instead of 4 weeks.
Patient presented to ED on 4/23/21 with chest pain, SOB, fever and body aches for 1 week with a low O2 sat and a positive covid test. Patient was treated for covid 19 and was discharged on 4/27/21.
This spontaneous report as received from a certified medical assistant refers to an unspecified number of patients of unknown age and gender. No information on patients' concurrent conditions, medical history or drug allergies was reported. On an unknown dates, the patients were vaccinated with improperly stored doses of VARIVAX (Merck) injection (Lot number L003775 and expiry date 04-FEB-2017) (dosing regimen and route were unknown). No information on patients' concomitant medications was provided. No adverse effects were reported. Lot number L003775 had been verified to be a valid lot number for VARIVAX (Merck). Follow-up information has been received on 03-AUG-2015. All telephone attempts to obtain follow up information had been unsuccessful. Follow-up information has been received on 05-AUG-2015. The Certified Medical Assistant reported that she would have to research the request made for patient identifiers, lot number, expiration date and dates of vaccination. The company fax number was reviewed with the reporter, if information becomes available. Follow-up information has been received from the medical assistant's clinic on 22-OCT-2015. The patient was 12 month old. The patient was vaccinated with improperly stored dose of VARIVAX (Merck) on 28-SEP-2015. This is one of the several reports received from the same reporter. Additional information has been requested. Patient, event, product and narrative information was updated.
Patient received Pneumovax on 6/7/06 to right deltoid. Patient returned 6/8/06 complaining swollen right deltoid . She was given Benadryl and Tylenol.
Pt. developed circumoral cyanosis followed by whiteness then circumoral cyanosis.  This occurred approx. 5 minutes.  Pt then slept all pm, all noc et all am next day.  Pt could be aroused but then went back to sleep.
vaccine exposure via breast milk; This spontaneous case was reported by a consumer and describes the occurrence of EXPOSURE VIA BREAST MILK (vaccine exposure via breast milk) in a 2-month-old infant of an unknown gender exposed to mRNA-1273 (Moderna COVID-19 Vaccine) , while the mother received the product for COVID-19 vaccination.    MEDICAL HISTORY (Parent): Concurrent medical conditions included Maternal exposure during breast feeding.    MEDICAL HISTORY (Patient): No medical history was provided by the reporter.    On 03-Mar-2021, the mother received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the mother received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 03-Mar-2021, the infant was diagnosed with EXPOSURE VIA BREAST MILK (vaccine exposure via breast milk). At the time of the report, EXPOSURE VIA BREAST MILK (vaccine exposure via breast milk) had resolved.            No Concomitant and Treatment medicines were Reported  Action taken with mRNA-1273 in response to the event was not applicable   This case was linked to MOD-2021-032346 (Parent-Child Link).   See case MOD-2021-032346 for details regarding the Parent case.
Patient flinched upon FLUVIRIN injection stating she felt injection pain up into her neck - pain & stiffness persisted into second day. Saw urgent care MD noting nothing remarkable. Pt. given Rx for cyclobenzaprine - sent home. Pt. came to pharmacy ask for recommendation referred to sports med. MD for follow up.
On May 21, 2022, I started having cold and flu like symptoms such as fever up to 100.0, fatigue, head congestion, cough and body aches. The next morning on 5-22, I still had these symptoms so I took a Covid home test with positive results. I called the urgent care center and spoke with a doctor on duty at that time who suggested to just quarantine for 5 days and wear a mask in public when released for 5 more days. On 5-23, I contacted my primary care doctor who prescribed PAXLOVID with no medical tests. I started taking it on 5-23 and took it for 5 days. I am feeling pretty good today. I am reporting a breakthrough case of Covid.
Very hyper and agitated the day after vaccination. Four days later she started crying and crying until no apparent reason which she never used to do that before.
Paralysis, weakness, numbness in bilateral lower extremities. Symptoms started 1/26/2021 resulting in hospitalization. Discharged on 1/28/2021 with Out-patient physical therapy
This spontaneous report as received from a other health professional refers to unspecified number of patient of unknown age and gender. Licensed nurse reported that since 17-JUL-2014, improperly stored (Merck) VARIVAX (dose, strength, route and lot number were not reported) was dispensed to patients. No adverse effects were noted. Follow up information has been received from Licensed Practical Nurse. Nurse did not have the information (patient identifiers, lot number, expiration date or dates of vaccine administration) available. Follow up information has been received from Licensed Practical Nurse referring to a 16 month old patient of unknown gender. On 29-SEP-2014 the patient was vaccinated with improperly stored (Merck) VARIVAX lot # J013905, expiration date 30-OCT-2015. This is one of several reports received from the same reporter. Additional information is not expected because all follow ups requested to complete the case were received.
Weakness, nausea, arm pain, headache, body aches, chills, tiredness, fever.
uncontrolled AFIB, 6 ICU admissions, added 7 cardiac medications. Swollen heart. Fluid retention, Tee Cardioversion
Left thigh 1 cm-size nodule with eczematous reaction size of quarter. Apply warm compress, steroid cream for dermatitis.
Information has been received from a health professional concerning a 7 year old male patient who was vaccinated on 12/13/2001 with a dose of varicella virus vaccine live.  Subsequently, on approximately 03/12/2004, the patient developed breakthrough chickenpox with less than 50 lesions.  Follow up information indicated that there was not a single report of adverse reaction following varicella vaccination.  The reporter indicated that 49 other patients developed breakthrough cases of chickenpox.  No additional information is expected.
Temp over 100; Achy body; Puking; Diarrhea; Initial information regarding this unsolicited valid non-serious social media case received from a consumer (patient) on 03-Dec-2020.  This case involves a patient with unknown demographics who had temp over 100 (Body temperature increased), achy body (Pain), puking (Vomiting) and diarrhea (Diarrhoea) when received vaccine INFLUENZA VACCINE.  The patient's medical history, past medical treatment(s), vaccination(s), family history and concurrent conditions were not provided.  Concomitant medications were not reported.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) (lot number, expiry date and other dosing details were not reported) for prophylactic vaccination  On an unknown date, (unknown latency) the patient did not get the flu but the last 3 flu shot within 24 hours led to the development of temp over 100 (Body temperature increased), achy body (Pain), puking (Vomiting) and diarrhea (Diarrhoea) for 3-4 days but it was not the flu, following the administration of INFLUENZA VACCINE.  Relevant laboratory test reported body temperature was 100.  It was not reported if the patient received a corrective medication for the events.  At the time of reporting, the outcome was unknown for the reported events.  There will be no information available on batch number for this case.
allergic to the vaccine; This case was reported by a consumer via interactive digital media and described the occurrence of allergy to vaccine in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced allergy to vaccine. On an unknown date, the outcome of the allergy to vaccine was unknown.   It was unknown if the reporter considered the allergy to vaccine to be related to Shingles vaccine.  Additional details were provided are as follows: The case was reported by patient himself/herself. The age at vaccination was not reported. The patient was vaccinated for shingles and was allergic to vaccine. The follow up would not be possible as no contact details were available.
SYNCOPE ON TWO OCCASIONS  11/11/2007 4pm and11/17/2007 6pm patient recover fully
Patient had swelling and soreness to injection site. She also had about 6 inches of redness around site.